September 2020 • 9/28/2020, New York
DECEMBER OF 2012, PARTICIPATED IN THE SERIES A PREFERRED EQUITY FINANCING FOR CRITICAL CARE DIAGNOSTICS, INC.
Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Their high sensitivity Presage® ST2 Assay measures the level of soluble ST2 in blood, identifying patients at increased risk of morbidity and mortality. ST2 has been evaluated in multiple clinical studies, now spanning more than 31,000 subjects.
*Testimonials contained on this website are not guaranteed for accuracy nor are they indicative of future results.